Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants: GlobalData
There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.